Summary
New treatments for psychiatric disorders are urgently required. Recent reviews show that there have been no improvements in efficacy of drugs for either affective disorders or schizophrenia since the first compounds were introduced over 40 years ago. Neuroactive lipids represent an entirely novel class of psychotropic compounds. Ethyl eicosapentaenoate is the first example of this group. Placebo-controlled studies have found it to be effective in depression, in treatment-unresponsive schizophrenia and in tardive dyskinesia. It is extremely well tolerated with none of the usual side-effects of either antidepressants or neuroleptics. It probably works by modulating post-receptor signal transduction processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
A. Khan, S.R. Khan, R.M. Leventhal and W.A. Brown: Am. J. Psychiatry1581449 (2001).
S.M. Gilbody, A.M. Bagnall, L. Duggan and A. Tuunainen: Cochrane Database Syst. Rev. CD002306 (2000).
L. Duggan, M. Fenton, R.M. Dardennes, A. El-Dosoky and S. Indran: Cochrane Database Syst. Rev. CD001359 (2000).
J. Geddes, N. Freemantle, P. Harrison and P. Bebbington: BMJ3211371 (2000).
I.M. Anderson: J. Affect Disord. 58, 19–36 (2000).
P. Bech, P. Cialdella, M.C. Haugh, M.A. Birkett, A. Hours, J.P. Boissel and G.D. Tollefson: Br. J. Psychiatry176421 (2000).
A. Khan, H.A. Warner and W.A. Brown: Arch. Gen. Psychiatry 57, 311 (2000).
A. Khan, S.R. Khan, R.M. Leventhal and W.A. Brown: Int. J. Neuropsychopharmacol.4113 (2001).
C. Barbui, M. Hotopf, N. Freemantle, J. Boynton, R. Churchill, M.P. Eccles, J.R. Geddes, R. Hardy, G. Lewis and J.M. Mason: Cochrane Database Syst. Rev.4CD002791 (2000).
W. Sneader: Drug discovery: The evolution of modern medicine, Wiley, Chichester 1985.
D. Healy: The antidepressant era, Harvard University Press, Cambridge 1997.
C. Holden: Science29429 (2001).
J.H. Austin: Chase, chance and creativity: the lucky art of novelty, Columbia University Press, New York 1985.
J. Thullier: Ten years that changed the face of mental illness, Martin Dunitz, London 1999.
D.F. Horrobin: J. R. Soc. Medicine93341 (2000).
D.F. Horrobin: Nat. Biotechnol.191099 (2001).
F. Hirata and J. Axelrod: Science2091082 (1980).
Y. Tsegaye, K.O. Daasvatn and H. Holmsen: Platelets1331 (2002).
M. Motoyoshi, M. Sugiyama, Y. Atomi, W. Kimura and H. Nagawa: Intern. J. Pancreatology2969 (2001).
P. Dieter, A. Kolada, S. Kamionka, A. Schadow and M. Kaszkin: Cell Signal14199 (2002).
V. Van Putten, Z. Refaat, C. Dessev, S. Blaine, M. Wick, L. Butterfield, S.Y. Han, L.E. Heasley and R.A. Nemenoff: J. Biol. Chem.2761226 (2001).
M. Hernandez, Y. Bayon, M. Sanchez Crespo and M.L. Nieto: J. Neurochem. 73, 1641 (1999).
J. Balsinde, M.A. Balboa and E.A. Dennis: Proc. Natl. Acad. Sci. USA957951 (1998).
M. Murakami, T. Kambe, S. Shimbara and I. Kudo: J. Biol. Chem.2743103 (1999).
J. Ishiguro, T. Tada, T. Ogihara, N. Ohzawa, K. Murakami and H. Kosuzume: J. Pharmacobiodyn.11251 (1988).
H.E. Krokan, K.S. Bjerve and E. Mork: Biochim. Biophys. Acta116859 (1993).
D.F. Horrobin and C.N. Bennett: Prostaglandins Leukot. Essent. Fatty Acids60141 (1999).
C.N. Bennett and D.F. Horrobin: Prostaglandins Leukot. Essent. Fatty Acids6347 (2000).
D.F. Horrobin: Human Psychopharmacol.1645 (2001).
I. Meloni, M. Muscettola, M. Raynaud, I. Longo, M. Bruttini, M.P. Moizard, M. Gomot, J. Chelly, V. des Portes, J.P. Fryns et al.: Nat. Genet. DOI: 10.1038/ng857 (2002).
E. Rassart, A. Bedirian, S. Do Carmo, O. Guinard, J. Sirois, L. Terrisse and R. Milne: Biochim. Biophys. Acta1482185 (2000).
E.A. Thomas, B. Dean, G. Pavey and J.G. Sutcliffe: Proc. Natl. Acad. Sci. USA984066 (2001).
M. Vogt and A. Skerra: J. Mol. Recognit.1479 (2001).
M.R. Witt, S.E. WesthHansen, P.B. Rasmussen, S. Hastrup and M. Nielsen: J. Neurochem.672141 (1996).
M.R. Witt and M. Nielsen: J. Neurochem.621432 (1994).
C.B. Bouzat and F.J. Barrantes: Receptors Channels1251 (1993).
S.S. Antollini and F.J. Barrantes: J. Biol. Chem.2771249 (2002).
A.A. Farooqui and L.A. Horrocks: Brain Res. Rev.16171 (1991).
J.W. Lazarewicz, E. Salinska and J.T. Wroblewski: Adv. Exp. Med. Biol.31873 (1992).
D. Piomelli, C. Pilon, B. Giros, P. Sokoloff, M.P. Martres and J.C. Schwartz: Nature 353, 164 (1991).
H.E. Xu, M.H. Lambert, V.G. Montana, D.J. Parks, S.G. Blanchard, P.J. Brown, D.D. Sternbach, J.M. Lehmann, G.B. Wisely, T.M. Willson et al.: Mol. Cell 3, 397 (1999).
A. Leaf and J.X. Kang: World Rev. Nutr. Diet8324 (1998).
J.X. Kang and A. Leaf: Am. J. Clin. Nutr.71202S (2000).
S.S. Palakurthi, R. Fluckiger, H. Aktas, A.K. Changolkar, A. Shahsafaei, S. Harneit, E. Kilic and J.A. Halperin: Cancer Res.602919 (2000).
L.C. Chiu, V.E. Ooi and J.M. Wan: Int. J. Oncol.19845 (2001).
M.J. Finnen and C.R. Lovell: Biochem. Soc. Trans.1991S (1991).
M. Peet, D.F. Horrobin and EPA Multicentre Study Group: J. Psychiatric Res.367 (2002).
M. Peet, D.F. Horrobin and E-E Multicentre Study Group: Arch. Gen. Psychiatryin press(2002).
B. Nemets, Z. Stahl and R.H. Belmaker: Am. J. Psychiatry159477 (2002).
US Food and Drug Administration, Dept of Health and Human Services: Fed. Regist.6230751 (1997).
Y. Shibutani, M. Kurokawa, K. Inoue, Y. Hamada and G. Yajima: Iyakuhin Kenkyu20826 (1989).
C.P. Burns, S. Halabi, G.H. Clamon, V. Hars, B.A. Wagner, R.J. Hohl, E. Lester, J.J. Kirshner, V. Vinciguerra and E. Paskett: Clin. Cancer Res.53942 (1999).
J.R. Hibbeln: Lancet3511213 (1998).
J.R. Hibbeln, in: M. Peet, I. Glen and D.F. Horrobin (eds.): Phospholipid spectrum disorder in psychiatry, Marius Press, Carnforth 1999, 195–210.
J.R. Hibbeln and N. Salem Jr.: Am. J. Clin. Nutr.621 (1995).
D.F. Horrobin: Schizophr. Res.53154 (2002).
P.B. Adams, S. Lawson, A. Sanigorski and A.J. Sinclair: Lipids31S157 (1996).
M. Maes, A. Christophe, J. Delanghe, C. Altamura, H. Neels and H.Y. Meltzer: Psychiatry Res.85275 (1999).
M. Maes, R. Smith, A. Christophe, P. Cosyns, R. Desnyder and H. Meltzer: J. Affect. Disord.3835 (1996).
C. Seko: Jpn. J. Hyg.52539 (1997).
M. Peet, B. Murphy, J. Shay and D. Horrobin: Biol. Psychiatry43315 (1998).
R. Edwards, M. Peet, J. Shay and D. Horrobin: J. Affect. Disord. 48, 149 (1998).
J. Lieb, R. Karmali and D. F. Horrobin: Prostaglandins Leukot. Med.10361 (1983).
J.R. Calabrese, R.G. Skwerer, B. Barna, D. Gulledge, R. Valenzuela, A. Butkus, S. Subichin and N.E. Krupp: Psychiatry Res.1741 (1986).
K. Ohishi, R. Ueno, S. Nishino, T. Sakai and O. Hayaishi: Biol. Psychiatry23326 (1988).
S. Nishino, R. Ueno, K. Ohishi, T. Sakai and O. Hayaishi: Am. J. Psychiatry146365 (1989).
M. Linnoila, A.R. Whorton, D.R. Rubinow, R.W. Cowdry, P.T. Ninan and R.N. Waters: Arch. Gen. Psychiatry40405 (1983).
R.M. Carney, M.W. Rich, A. teVelde, J. Saini, K. Clark and K.E. Freedland: J. Psychosom. Res.32159 (1988).
R. Krittayaphong, W.E. Cascio, K.C. Light, D. Sheffield, R.N. Golden, J.B. Finkel, G. Glekas, G.G. Koch and D.S. Sheps: Psychosom. Med.59231 (1997).
J.H. Christensen, P. Gustenhoff, E. Korup, J. Aaroe, E. Toft, J. Moller, K. Rasmussen, J. Dyerberg and E.B. Schmidt: Br. Med. J.312677 (1996).
M.L. Burr, A.M. Fehily, J.F. Gilbert, S. Rogers, R.M. Holliday, P.M. Sweetnam, P.C. Elwood and N.M. Deadman: Lancet2757 (1989).
R.B. Singh, M.A. Niaz, J.P. Sharma, R. Kumar, V. Rastogi and M. Moshiri: Cardiovasc. Drugs Ther.11485 (1997).
Gruppo Italiano per to Studio della Streptochinasi nell’Infarto Miocardico (GISSI): Lancet 354, 447 (1999).
S. Endres, R. Ghorbani, V.E. Kelley, K. Georgilis, G. Lonnemann, J.W.M. vanderMeer, J.G. Cannon, T.S. Rogers, M.S. Klempner, P.C. Weber et al.: N. Engl. J. Med.320265 (1989).
P. Purasiri, A. McKechnie, S.D. Heys and O. Eremin: Immunology92166 (1997).
D.F. Horrobin, in: E. Chiu, D. Ames and C. Katona (eds.): Vascular disease and affective disorders, Martin Dunitz, London 2002, 75–94.
A. Coppen and J. Bailey: J. Affect. Disord.60121 (2000).
B.K. Puri, S.J. Counsell, A.J. Richardson and D.F. Horrobin: Arch. Gen. Psychiatry5991 (2002).
M.P. Freeman: Ann. Clin. Psychiatry12159 (2000).
M. Peet, I. Glen and D.F. Horrobin (eds.): Phospholipid spectrum disorder in psychiatry, Marius Press, Carnforth 1999.
D.F. Horrobin: Postgrad. Med. J.53(Suppl. 4), 160 (1977).
D.F. Horrobin: Schizophr. Res.29102 (1998).
D.F. Horrobin, A.I. Glen and K. Vaddadi: Schizophr. Res.13195 (1994).
D.F. Horrobin: J. Orthomolecular Psychiatry933 (1980).
P. Ward, J. Sutherland, E. Glen, A.I.M. Glen and D.F. Horrobin: Schizophr. Res.2470 (1997).
C.J. Hudson, A. Lin, S. Cogan, F. Cashman and J.J. Warsh: Biol. Psychiatry41507 (1997).
G.E. Berger, H.P. Yuen and P.D. McGorry: Schizophr. Res.53538 (2002).
R. Reddy and J.K. Yao, in: M. Peet, I. Glen and D.F. Horrobin (eds.): Phospholipid spectrum disorder in psychiatry, Marius Press, Carnforth 1999, 75–88.
S.P. Mahadik, S. Sitasawad and M. Mulchandani, in: M. Peet, I. Glen and D.F. Horrobin (eds.): Phospholipid spectrum disorder in psychiatry, Marius Press, Carnforth 1999, 99–111.
J.K. Yao, R.D. Reddy, J.W. Pettegrew, D.P. vanKammen, D.F. Horrobin and S.P. Mahadik: Biol. Psychiatry4758S (2000).
J.W. Pettegrew, M.S. Keshavan, K. Panchalingam, S. Strychor, D.B. Kaplan, M.G. Tretta and M. Allen: Arch. Gen. Psychiatry48563 (1991).
P. Williamson, D. Drost, J. Stanley, T. Carr, S. Morrison and H. Merskey: Arch. Gen. Psychiatry48578 (1991).
L. Demisch, H. Gerbaldo, P. Gebhart, K. Georgi and H.J. Bochnik: Psychiatry Res.22275 (1987).
J.K. Yao, D.P. van Kammen and J.A. Gurklis: Psychiatry Res.6011 (1996).
K.S. Vaddadi, P. Courtney, C.J. Gilleard, M.S. Manku and D.F. Horrobin: Psychiatry Res.27313 (1989).
M. Peet, J. Laugharne, N. Rangarajan, D.F. Horrobin and G. Reynolds: J. Psychiatr. Res.29227 (1995).
J.E. Mellor, J.D.E. Laugharne and M. Peet: Schizophr. Res.1885 (1995).
A. Nilsson, D.F. Horrobin, A. Rosengren, L. Waller, A. Adlerberth and L. Wilhelmsen: Prostaglandins Leukot. Essent. Fatty Acids5583 (1996).
R. Reddy, J.K. Yao, M. Zeigler and M.S. Keshavan: Schizophr. Res.36108 (1999).
S.P. Mahadik and R.E. Scheffer: Prostaglandins Leukot. Essent. Fatty Acids5545 (1996).
M. Peet, J. Brind, C.N. Ramchand, S. Shah and G.K. Vankar: Schizophr. Res.49243 (2001).
M. Peet and J. Mellor: Schizophr. Res.29160 (1998).
D.F. Horrobin, K. Jenkins, C.N. Bennett and W.W. Christie: Prostaglandins Leukot. Essent. Fatty Acidsin press.
R.A. Emsley, C.C. Myburgh, P.P. Oosthuizen and S.J. vanRensburg: Schizophr. Res. 53, 9 (2002).
W.S. Fenton, F. Dickerson, J. Boronow, J.R. Hibbeln and M. Knable: Am. J. Psychiatry1582071 (2001).
A.L. Stoll, W.E. Severus, M.P. Freeman, S. Rueter, H.A. Zboyan, E. Diamond, K.K. Cress and L.B. Marangell: Arch. Gen. Psychiatry56407 (1999).
D.F. Horrobin and M.S. Manku: Br. Med. J.2801363 (1980).
M.C.J. Chang and C.R. Jones: Neurochem. Res.23887 (1998).
F. Bosetti, J. Rintala, R. Seeman, T.A. Rosenburger, M.A. Conteras, S.I. Rapoport and M.C. Chang: Mol. Psychiatryin press(2002).
B.M. McGahon, D.S.D. Martin, D.F. Horrobin and M.A. Lynch: Neuroscience94305 (1999).
J.J. Clifford, J. Drago, A.L. Natoli, J.Y.F. Wong, A. Kinsella, J.L. Waddington and K.S. Vaddadi: Neuroscience10981 (2002).
K.S. Vaddadi, E. Soosai, E. Chiu and P. Dingjan: Neuroreport1329 (2002).
B.K. Puri, G.M. Bydder, S.J. Counsell, B.J. Corridan, A.J. Richardson, J.V. Hajnal, C. Appel, H.M. McKee, K.S. Vaddadi and D.F. Horrobin: Neuroreport13123 (2002).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Basel AG
About this chapter
Cite this chapter
Horrobin, D.F. (2002). A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E). In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 59. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8171-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8171-5_6
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9464-7
Online ISBN: 978-3-0348-8171-5
eBook Packages: Springer Book Archive